Clinical Trials Directory

Trials / Unknown

UnknownNCT02882438

Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis

Glucosamine Sulphate and Ginkgo Biloba for Treating Tinea Pedis

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Ahmed A. H. Abdellatif · Academic / Other
Sex
All
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

Tinea Pedis infected the feet of about 20-25% of the world population. Tinea Pedis is a fungal infection of the feet and it is easily spread. Oral therapy is usually used for chronic conditions or when topical treatment has failed. The aim of this study is to prove the antifungal and antibacterial activity of Ginko Biloba (GKB) \& Glucosamine (GL) as separate material or both in combination.

Detailed description

Ginko Biloba (GKB) \& Glucosamine (GL) were formulated in different dosage forms such as capsules, hydrogel and spray. GKB\&GL were in filled in hard gelatin capsules as three formulae (GKB caps, GL caps and both as mixture in caps). Also, GKB\&GL were formulated in hydrogel using 2% carbopol 934 as three formulae (GKB only, GL only and both as mixture). The same also were formulated as spray using alcohol, water and glycerol in concentration of 60%, 20% and 20% respectively. The study included 5 trials, involving 35 participants. The oral formulae were tried on 30 participants having Tenia Pedis. Fluconazole was as standard antifungal drug.The antifungal activity of all gel formulae was determined by Agar well-diffusion method. It is also important to follow up and collect data, preferably for six months for local and systemic activity, to establish whether or not the infection recurred or not. In future clinical trials, research should consider the costs of the different treatment approaches.

Conditions

Interventions

TypeNameDescription
DRUGinfected groupGinkgo Biloba in different dosage forms
DRUGcontrol groupplacebo without Ginkgo Biloba

Timeline

Start date
2016-01-01
Primary completion
2020-09-01
Completion
2022-10-01
First posted
2016-08-29
Last updated
2019-10-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT02882438. Inclusion in this directory is not an endorsement.